Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2019-2025

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.
North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.
In 2018, the global Oral Antidiabetic (OAD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Oral Antidiabetic (OAD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Antidiabetic (OAD) Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Eli Lilly
Merck
Sanofi
AstraZeneca
Glenmark
Novartis
Boehringer Ingelheim
Novo Nordisk
Mannkind

Market segment by Type, the product can be split into
Sulphonylureas
Biguanides
Intestinal α-Glucosidase Inhibitors
Others

Market segment by Application, split into
Hospital
Clinics
Diabetics Treatment Centres
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oral Antidiabetic (OAD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Oral Antidiabetic (OAD) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oral Antidiabetic (OAD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.